Latest KFF Health News Stories
KFF Health News' 'What the Health?': On Abortion Rights, Ohio Is the New Kansas
Nearly a year to the day after Kansas voters surprised the nation by defeating an anti-abortion ballot question, Ohio voters defeated a similar, if cagier, effort to limit access in that state. This week, they rejected an effort to raise the threshold for approval of future ballot measures from a simple majority, which would have made it harder to protect abortion access with yet another ballot question come November. Meanwhile, the number of Americans without health insurance has dropped to an all-time low, though few noticed. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Roubein of The Washington Post, and Emmarie Huetteman of KFF Health News join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews Kate McEvoy, executive director of the National Association of Medicaid Directors, about how the “Medicaid unwinding” is going, as millions have their eligibility for coverage rechecked.
Seeking Medicare Coverage for Weight Loss Drugs, Pharma Giant Courts Black Influencers
Novo Nordisk, the dominant company in the multibillion-dollar market for weight loss drugs, focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease that needs treatment.
Survey: Americans Want Weight Loss Drugs Despite High Cost
A new poll reveals enthusiasm for a pricey new generation of weight loss drugs, but interest drops if users potentially have to deal with weekly injections, lack of insurance coverage, or a need to continue the medications indefinitely to avoid regaining weight.
New Weight Loss Drugs Carry High Price Tags and Lots of Questions for Seniors
Although nearly 40% of Americans 60 and older are obese, Medicare doesn’t cover weight loss medications. Meanwhile, studies haven’t thoroughly examined new drugs’ impact on older adults.
En las personas mayores, un poco de sobrepeso no es tan malo
Comprender las pruebas científicas y la opinión de los expertos sobre los problemas de peso en los adultos mayores no es fácil.
In Older Adults, a Little Excess Weight Isn’t Such a Bad Thing
Researchers have found that while obesity at any age risks harming health, a few extra pounds in later life isn’t cause for concern.
Got Milk in School? Farmers Fight Health Advocates Over the Creamy ‘Whole’ Variety
It has been over a decade since whole milk was served in schools through the National School Lunch Program, after U.S. government dietary guidance effectively banned it. But dairy farmers, some health experts, and members of Congress say it’s time to bring it back.
Lose Weight, Gain Huge Debt: NY Provider Has Sued More Than 300 Patients Who Had Bariatric Surgery
The private equity-backed practice has been known to demand more than $100,000 in charges or penalties. One patient is fighting back.
Redes sociales alimentan obsesión por las drogas para bajar de peso, sin hablar de riesgos
La competencia para hacerse con un mercado que podría valer $100.000 millones al año, solo para los fabricantes de medicamentos, ha desencadenado una ola de publicidad que preocupa a las autoridades sanitarias y médicos de todo el mundo.
Social Media Is Fueling Enthusiasm for New Weight Loss Drugs. Are Regulators Watching?
Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.
Readers and Tweeters Decry Medical Billing Errors, Price-Gouging, and Barriers to Benefits
KHN gives readers a chance to comment on a recent batch of stories.
Muchos estadounidenses han recurrido a la última gran idea para perder peso; ya sean dietas de moda, la obsesión por el fitness, hierbas y píldoras poco fiables o la cirugía bariátrica. Parece que nunca acaban siendo la solución mágica con la que la gente sueña.
Patients Complain Some Obesity Care Startups Offer Pills, and Not Much Else
A new wave of obesity care startups offer access to new weight loss medications. But do they offer good health care?
Readers and Tweeters Take Positions on Sleep Apnea Treatment
KHN gives readers a chance to comment on a recent batch of stories.
You may have seen the ads that promise weight loss and better health — phone apps, rings, and other devices — by giving you data on how your body reacts to food, exercise, and sleep. Is this information enough to help consumers achieve their goals?
La nueva generación de medicamentos para la pérdida de peso es prometedora, pero tiene un precio
Algunos pacientes, según los especialistas en medicina de la obesidad, experimentan una disminución de la presión arterial, un mejor control de la diabetes, menos dolor en las articulaciones y un mejor sueño gracias a estos nuevos tratamientos.
New Generation of Weight Loss Medications Offer Promise — But at a Price
People now have at their disposal more medicines that are effective at reducing weight, but none can counter obesity alone. One big problem: Insurance coverage remains spotty, and the costly drugs may be needed long term.
Índice de masa corporal: una medida errónea del peso que afecta el tratamiento de la obesidad
Los tratamientos actuales para la obesidad y los trastornos alimentarios, y sus costos, muchas veces se basan en esta medida que no está amparada en la ciencia.
BMI: The Mismeasure of Weight and the Mistreatment of Obesity
The human body mass index — a simple mathematical equation — is tied to a measure of obesity invented almost 200 years ago. On the downside, it can stand between patients and treatment for weight issues. It particularly mismeasures Black women and Asians.
A Free-for-All From Readers and Tweeters, From Medical Debt to Homelessness
KHN gives readers a chance to comment on a recent batch of stories.